Associated Papers
Succinate dehydrogenase variants in paraganglioma: why are B subunit variants 'bad'?
Gruber LM et al.
Endocrine Oncology (bristol, England), 2023
37434649 (PubMed )
Supplement: supplementary_table_1.xlsx › Truncating_Variants
Paragangliomas arise through an autonomous vasculo-angio-neurogenic program inhibited by imatinib.
Verginelli F et al.
Acta Neuropathologica, 2018
29305721 (PubMed )
Supplement: 401_2017_1799_MOESM1_ESM.pdf
Integrative genetic, epigenetic and pathological analysis of paraganglioma reveals complex dysregulation of NOTCH signaling.
Cama A et al.
Acta Neuropathologica, 2013
23955600 (PubMed )
Supplement: 401_2013_1165_MOESM1_ESM.pdf
Head and neck paragangliomas: genetic spectrum and clinical variability in 79 consecutive patients.
Piccini V et al.
Endocrine-related Cancer, 2012
The succinate dehydrogenase genetic testing in a large prospective series of patients with paragangliomas.
Burnichon N et al.
The Journal of Clinical Endocrinology and Metabolism, 2009
Select a paper to view details